Literature DB >> 10817745

Antileishmanial activities of stearylamine-bearing liposomes.

T Dey1, K Anam, F Afrin, N Ali.   

Abstract

Here we report the activity of liposomes comprising egg phosphatidylcholine (PC) and stearylamine (SA) against Leishmania donovani parasites. Both promastigotes and intracellular amastigotes in vitro and in vivo were susceptible to SA-PC liposomes. A single dose of 55 mg of SA-PC liposomes/animal could significantly reduce the hepatic parasite burden by 85 and 68% against recent and established experimental visceral leishmaniasis, respectively, suggesting their strong therapeutic potential.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10817745      PMCID： PMC89949          DOI： 10.1128/AAC.44.6.1739-1742.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

1.  The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.

Authors:  C D Black; G J Watson; R J Ward
Journal:  Trans R Soc Trop Med Hyg       Date:  1977       Impact factor: 2.184

2.  Trypanocidal activity of the stearylamine-bearing liposome in vitro.

Authors:  E Yoshihara; H Tachibana; T Nakae
Journal:  Life Sci       Date:  1987-06-01       Impact factor: 5.037

3.  Leishmania donovani: surface membrane carbohydrates of promastigotes.

Authors:  D M Dwyer
Journal:  Exp Parasitol       Date:  1977-04       Impact factor: 2.011

4.  Liposomal amphotericin B in drug-resistant visceral leishmaniasis.

Authors:  R N Davidson; S L Croft; A Scott; M Maini; A H Moody; A D Bryceson
Journal:  Lancet       Date:  1991-05-04       Impact factor: 79.321

5.  Leishmania mexicana amazonensis: surface charge of amastigote and promastigote forms.

Authors:  P F Pimenta; W de Souza
Journal:  Exp Parasitol       Date:  1983-10       Impact factor: 2.011

Review 6.  Delivery of liposome-encapsulated drugs to macrophages.

Authors:  C R Alving
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

7.  Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes.

Authors:  C R Miller; B Bondurant; S D McLean; K A McGovern; D F O'Brien
Journal:  Biochemistry       Date:  1998-09-15       Impact factor: 3.162

8.  In vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylamine-bearing liposomes.

Authors:  H Tachibana; E Yoshihara; Y Kaneda; T Nakae
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

9.  Protection of Toxoplasma gondii-infected mice by stearylamine-bearing liposomes.

Authors:  H Tachibana; E Yoshihara; Y Kaneda; T Nakae
Journal:  J Parasitol       Date:  1990-06       Impact factor: 1.276

10.  Cell surface lipophosphoglycan of Leishmania donovani.

Authors:  D L King; Y D Chang; S J Turco
Journal:  Mol Biochem Parasitol       Date:  1987-05       Impact factor: 1.759
View more
  10 in total

Review 1.  Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.

Authors:  Roma Sinha; Jayeeta Roychoudhury; Partha Palit; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

3.  Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major.

Authors:  Douglas R Rice; Paola Vacchina; Brianna Norris-Mullins; Miguel A Morales; Bradley D Smith
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

4.  Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.

Authors:  Antara Banerjee; Manjarika De; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

5.  Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis.

Authors:  Partha Palit; Abhijit Hazra; Arindam Maity; R S K Vijayan; Prabu Manoharan; Sukdeb Banerjee; Nirup B Mondal; Nanda Ghoshal; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2011-10-24       Impact factor: 5.191

6.  Preparation, characterization, and evaluation of eosin B-loaded nano-liposomes for growth inhibition of Plasmodium falciparum.

Authors:  Mana Najafzadeh; Haleh Bakhshandeh; Zahra Zamani; Monire Movahedi; Seyed Mohammad Atyabi
Journal:  Parasitol Res       Date:  2022-01-06       Impact factor: 2.289

Review 7.  Leishmaniasis treatment--a challenge that remains: a review.

Authors:  Dilvani O Santos; Carlos E R Coutinho; Maria F Madeira; Carolina G Bottino; Rodrigo T Vieira; Samara B Nascimento; Alice Bernardino; Saulo C Bourguignon; Suzana Corte-Real; Rosa T Pinho; Carlos Rangel Rodrigues; Helena C Castro
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

8.  Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.

Authors:  Swati Pal; Rajesh Ravindran; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice.

Authors:  Jayeeta Roychoudhury; Roma Sinha; Nahid Ali
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

10.  Inhibition of the Growth of Plasmodium falciparum in Culture by Stearylamine-Phosphatidylcholine Liposomes.

Authors:  Gulam Mustafa Hasan; Neha Garg; Enna Dogra; Ranu Surolia; Prahlad Chandra Ghosh
Journal:  J Parasitol Res       Date:  2011-06-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.